Financial Statements

Boston Scientific Corporation (BSX)

$65.74

-0.48 (-0.72%)
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers are in thousands , Years are calendar years not fiscal years

Retained Earning Schedule

Year 2023 2022 2021 2020 2019
Retained Earnings (Previous Year) -750-1,392-2,378-2,253-
Net Income 1,570643986-1404,700
Stock Dividends 27545543-6,953
Dividend Paid -28-55-55-28-
Retained Earnings 819-750-1,392-2,378-2,253

PPE Schedule

Year 2023 2022 2021 2020 2019
Gross PPE 2,8312,6862,5412,415-
Annual Depreciation 7397576995022,876
Capital Expenditure -711-612-554-376-461
Net PPE 2,8592,8312,6862,5412,415

Intangible and Goodwill Schedule

Year 2023 2022 2021 2020 2019
Intangible and Goodwill (Previous Year) -10,1769,95111,98812,920
New Purchases -348-14696--
Intangible and Goodwill 10,1769,95111,98812,92014,387

Boston Scientific Corporation income statement is the only one that provides an overview of company sales and net income
The reasoning behind the adjustment, however, is that free cash flow is meant to measure money being spent right now, not transactions that happened in the past. This makes Boston Scientific Corporation FCF a useful instrument for identifying growing companies with high up-front costs, which may eat into earnings now but have the potential to pay off later.